Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cantacuzino 2010-2011 seasonal trivalent inactivated influenza vaccine study in adults
2010-023105-35Phase 3Active
- Sponsor
- Cantacuzino Institute
- Start
- Jun 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of trivalent purified inactivated influenza vaccine in influenza (2 arms), sponsored by Cantacuzino Institute. Primary endpoint: Safety profile. Started Jun 2011; status: active.
02
Drugs
trivalent purified inactivated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2010-023105-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023105-35.